the onset of palsy. Also, peripheral nerve conduction studies were performed within 4 weeks of onset of neurological symptoms and were repeated if the initial conduction studies were normal. Patients were classified as having acute inflammatory demyelinating polyradiculoneuropathy (AIDP) or acute motor sensory axonal neuropathy (AMSAN) on the basis of the electrodiagnostic criteria proposed by Ho et al.
.
The complete blood count, liver function tests, plasma urea, creatinine, electrolyte, and plasma glucose levels, antinuclear antibody, thyroid function, antiacetylcholine receptor antibodies, thyroid peroxidase antibodies, antinuclear antibody and CSF biochemical parameters were evaluated.
Virological and microbiological studies evaluated a variety of infections (Borrelia burgdorferi, syphillis HSV-1/2, VZV, EBV, CMV, HHV-6) in the serum and CSF. Serum IgG and IgM antibodies to gangliosides GM1, GM2, GM1b, GD1a, GD1b, GalNAc-GD1a, GT1a, and GQ1b were investigated by enzyme-linked immunosorbent assay (ELISA).
Patients received treatment during hospitalization and outpatient records after discharge were examined. Improvements in levels of FD were evaluated over a period of 1-3 months.
results
Seventeen patients with FD were detected/analysed for the underlying causes. Twelve of the patients were female and five of them were male. Eleven patients (64.7%) were diagnosed with GBS fulfilling the clinical and electrophysiological criteria 6 . Different subtypes of GBS based on electrophysiological abnormalities included AIDP in 10, AMSAN in 1 patients. One of them presented with FD at the onset of illness and other patients developed FD 2-7 days after onset GBS. IVIG was administered to these patients and only one patient died. Complete recovery was seen in four patients and partial recovery was observed in six. Data on the patients are provided in Table. Other etiological factors in our patients was detected; brainstem encephalitis (1), neurosarcoidosis (1), non-Hodgkin' s Lymphoma (1), tuberculous meningitis (1), herpes simplex reactivation (1), and idiopathic (1). The patients who had tuberculous meningitis and non-Hodgkin' s Lymphoma died.
Two patients had developed FD during pregnancy. One of these patients was diagnosed with tuberculous meningitis and did not respond to treatment and later died. The other pregnant patient was considered to have idiopathic FD and partially recovered with steroid therapy.
disCussion
The most important part of the evaluation of a patient with FD is a thorough history and physical examination focusing on the head and neck region and the neurological system. The work-up should include complete blood count, fasting glucose, erythrocyte sedimentation rate, fluorescent treponemal antibody test, HIV test, Lyme titer, and antinuclear antibody level measurement. Contrast-enhanced MRI scan, if done in the appropriate clinical setting, may detect a positive radiographic diagnosis. The areas that are most important to visualize are the central nervous system, skull base, meninges, and cerebellopontine angle. Lumbar puncture after an MRI scan as well as special facial nerve function tests can also be performed.
One of the most common underlying causes of FD is GBS. During the course of illness, 24-60% of GBS patients develop facial nerve paresis, and almost all show it bilaterally 7 . Also, Miller Fisher syndrome is considered a variant of GBS, and FD may be seen 8 . In a 23-year review, Keane et al. found that out of 43 patients with FD as the predominant sign, GBS were one of the common underlying causes. Among the cases, two out of the five with GBS progressed clinically; information on the others was not available 2 . Eleven patients (64.7%) were diagnosed with GBS in our study, one of them presented with FD at the onset of illness. Ten patients developed FD, 2-7 days after onset GBS. In our study, the most common cause of FD was GBS. Anti-ganglioside antibody tests were administered our patients but they were not detected. Purely isolated FD associated with distinctly positive anti-GM2, anti-GD1a, and anti-GD1b antibodies is exceedingly rare 9 . On the other hand, we more frequently observed AIDP in patients with FD. However, we cannot speculate on the possible cause of this, because AIDP is the most common form of GBS 6 . Causes of FD other than GBS are very diverse. Active HSV-1 infections as well as post-infectious immune-mediated mechanism have been associated with facial paralysis. HSV-1 DNA has been found by PCR analysis in biological samples of patients with unilateral facial paralysis. Also, HSV-1 related FD is rarely monitored 10 . HSV-1 DNA was detected in the CSF of one patient, and we think that it could indicate a possible viral association with FD.
Effects of lymphoma on the peripheral nervous system have been reviewed 11 . In the literature, Re et al. described a case of GBS in a patient with non-Hodgkin' s lymphoma, and FD was seen in that patient. It is unusual to see neurological symptoms such as FD in patients with malignant lymphoma. Acute lymphoblastic leukemia may present with FD
12
. On the other hand, lymphomatous meningitis is a profoundly morbid and often fatal CNS metastasis that develops in at least 4%-8% of patients with non-Hodgkin lymphoma 13 . Facial diplegia can be developed lymphomatous meningitis. Our patient used vincristine for lymphoma treatment. Vincristine-induced neurotoxicity has been reported, especially as cranial and peripheral neuropathy 14 . Also, we detected multiple cranial neuropathies. Facial diplegia may be associated with vincristine-induced neurotoxicity or lymphomatous meningitis.
Facial diplegia is very rarely seen during pregnancy. A few cases have been reported. Many factors may lead to FD during pregnancy. Idiopathic cases have been reported 15 . We identified two pregnant patients with FD. Tuberculous meningitis was determined one patient and the other was considered idiopathic. According to Mari et al., FD seems to be more frequent during the last trimester of pregnancy and in the early postpartum period 15 . Facial diplegia was seen our patients in the last trimester. The tuberculous meningitis patient did not respond to any treatment and subsequently died. The patient with idiopathic FD had a partial recovery.
Also, the etiology of FD includes many conditions such as congenital, Bickerstaff ' s brainstem encephalitis, tuberculous meningitis, sarcoidosis traumatic, Lyme disease, diabetes mellitus, metabolic, toxic (thallium), and immunoallergic 2, 16, 17, 18, 19, 20, 21, 22, 23 . In our study, we did not detect Hansen' s disease, syphilis, Lyme disease, intracranial tumors or cryptococcal meningitis, unlike the studies from Keane et al.
.
We detected HSV-1, neurosarcoidosis and non-Hodgkin' s lymphoma. This condition may arise from early diagnosis, new developments of laboratory tests and treatments.
Treatment for patients with facial paralysis varies according to the etiology. Clinical evaluation for both the severity of paralysis and the presence of complications is the first step before the start of treatment or rehabilitation. In FD with GBS, the standard treatments for GBS are reasonable . Short-term steroid therapy is beneficial for patients with idiopathic FD. In herpes zoster infections, acyclovir may be a useful treatment approach in Bell' s palsy 24 . Corticosteroid therapy is recommended in most cases of neurosarcoidosis with FD as spontaneous recovery cannot be predicted 25 . Treatment protocol of FD is not clear in the pregnancy and it depends on underlying cause. Corticosteroids did not appear to influence the outcome of Bell' s palsy in pregnancy 26 . On the other hand, corticosteroid therapy is controversial in pregnant patients with FD. However, in our patient, a partial recovery was seen with corticosteroid treatment.
Limitations of this study are short follow-up period, the abscense of different outcome scores obtained by interviews and the small size of the study group. Another limitation is that we could not evaluate the effect of FD on the prognosis of GBS as the present study is a retrospective study.
In conclusion, FD may be due to a life-threatening condition. Therefore, the practitioner should be aware of the diagnostic possibilities that cause this extremely rare condition and treat.
